Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Biophytis announces the drawing of the last tranche  of ORNANE under the 2020 Atlas Contract for €3 million
Biophytis announces the drawing of the last tranche of ORNANE under the 2020 Atlas Contract for €3 million
Biophytis announces the drawing of the last tranche of ORNANE under the 2020 Atlas Contract for €3 million
DGAP-News: home24 SE: Alliance for growth: home24 acquires home accessories direct to consumer brand Butlers and expands its market position
DGAP-News: home24 SE: Alliance for growth: home24 acquires home accessories direct to consumer brand Butlers and expands its market position
DGAP-News: home24 SE: Alliance for growth: home24 acquires home accessories direct to consumer brand Butlers and expands its market position
DGAP-Adhoc: home24 SE: home24 SE acquires Butlers Group
DGAP-Adhoc: home24 SE: home24 SE acquires Butlers Group
DGAP-Adhoc: home24 SE: home24 SE acquires Butlers Group
EQS-Adhoc: Cicor publishes a supplement to the preliminary prospectus regarding the planned issuance of mandatory convertible notes
EQS-Adhoc: Cicor publishes a supplement to the preliminary prospectus regarding the planned issuance of mandatory convertible notes
EQS-Adhoc: Cicor publishes a supplement to the preliminary prospectus regarding the planned issuance of mandatory convertible notes
Pharnext and Global Tech Opportunities 13 Agree to Stop Convertible Bond Program from End of May 2022
Pharnext and Global Tech Opportunities 13 Agree to Stop Convertible Bond Program from End of May 2022
Pharnext and Global Tech Opportunities 13 Agree to Stop Convertible Bond Program from End of May 2022
DGAP-News: ENAPTER AG CONCLUDES SUBSCRIPTION OFFER FOR CASH CAPITAL INCREASE
DGAP-News: ENAPTER AG CONCLUDES SUBSCRIPTION OFFER FOR CASH CAPITAL INCREASE
DGAP-News: ENAPTER AG CONCLUDES SUBSCRIPTION OFFER FOR CASH CAPITAL INCREASE
ENOGIA: Signing of an agreement with the Eiffel Gaz Vert fund
ENOGIA: Signing of an agreement with the Eiffel Gaz Vert fund
ENOGIA: Signing of an agreement with the Eiffel Gaz Vert fund
EQS-Adhoc: ASMALLWORLD AG to acquire a 10% stake in Global Hotel Alliance
EQS-Adhoc: ASMALLWORLD AG to acquire a 10% stake in Global Hotel Alliance
EQS-Adhoc: ASMALLWORLD AG to acquire a 10% stake in Global Hotel Alliance
EQS-News: Mobimo Holding AG: Mobimo strengthens portfolio and pipeline with acquisitions in the canton of Zurich and French-speaking Switzerland
EQS-News: Mobimo Holding AG: Mobimo strengthens portfolio and pipeline with acquisitions in the canton of Zurich and French-speaking Switzerland
EQS-News: Mobimo Holding AG: Mobimo strengthens portfolio and pipeline with acquisitions in the canton of Zurich and French-speaking Switzerland
ROSTELECOM PJSC: Rostelecom acquires MVNE platform provider
ROSTELECOM PJSC: Rostelecom acquires MVNE platform provider
ROSTELECOM PJSC: Rostelecom acquires MVNE platform provider
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Playtech plc
Form 8.3 - The Vanguard Group, Inc.: Playtech plc
Form 8.3 - The Vanguard Group, Inc.: Playtech plc
DGAP-Adhoc: bet-at-home.com AG: winding up of a Maltese Group company
DGAP-Adhoc: bet-at-home.com AG: winding up of a Maltese Group company
DGAP-Adhoc: bet-at-home.com AG: winding up of a Maltese Group company
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
The Vanguard Group, Inc.:Avast plc
The Vanguard Group, Inc.:Avast plc
The Vanguard Group, Inc.:Avast plc
DGAP-News: SBF confirms 2021 growth targets after strong business performance in the second half of the year
DGAP-News: SBF confirms 2021 growth targets after strong business performance in the second half of the year
DGAP-News: SBF confirms 2021 growth targets after strong business performance in the second half of the year
Turkiye Garanti Bankasi A.S.: TRFGRANA2112 ISIN- Redemption of the Debt Instrument
Turkiye Garanti Bankasi A.S.: TRFGRANA2112 ISIN- Redemption of the Debt Instrument
Turkiye Garanti Bankasi A.S.: TRFGRANA2112 ISIN- Redemption of the Debt Instrument
DGAP-Adhoc: asknet Solutions AG: Le Nouveau Holdings Inc. becomes new majority shareholder
DGAP-Adhoc: asknet Solutions AG: Le Nouveau Holdings Inc. becomes new majority shareholder
DGAP-Adhoc: asknet Solutions AG: Le Nouveau Holdings Inc. becomes new majority shareholder
Arix Bioscience PLC: Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals
Arix Bioscience PLC: Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals
Arix Bioscience PLC: Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals